<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004123A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004123</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13870804</doc-number><date>20130425</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>GB</country><doc-number>0304363.5</doc-number><date>20030226</date></priority-claim><priority-claim sequence="02" kind="national"><country>GB</country><doc-number>0318431.4</doc-number><date>20030806</date></priority-claim><priority-claim sequence="03" kind="international"><country>IB</country><doc-number>PCT/IB2004/001071</doc-number><date>20030806</date></priority-claim><priority-claim sequence="04" kind="national"><country>GB</country><doc-number>0325391.1</doc-number><date>20031030</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>10</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>P</subclass><main-group>21</main-group><subgroup>00</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>1027</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>P</subclass><main-group>21</main-group><subgroup>005</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>4241471</main-classification><further-classification>435 704</further-classification><further-classification>435  5</further-classification><further-classification>435 696</further-classification></classification-national><invention-title id="d0e115">MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>13275017</doc-number><date>20111017</date></document-id><parent-status>PENDING</parent-status></parent-doc><child-doc><document-id><country>US</country><doc-number>13870804</doc-number></document-id></child-doc></relation></continuation><division><relation><parent-doc><document-id><country>US</country><doc-number>11719835</doc-number><date>20070521</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8071371</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13275017</doc-number></document-id></child-doc></relation></division></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Institute For Research in Biomedicine</orgname><address><city>Bellinzona</city><country>CH</country></address></addressbook><residence><country>CH</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Lanzavecchia</last-name><first-name>Antonio</first-name><address><city>Bellinzona</city><country>CH</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Institute For Research in Biomedicine</orgname><role>03</role><address><city>Bellinzona</city><country>CH</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">A method for producing a clone of an immortalised human B memory lymphocyte, comprising the step of transforming human B memory lymphocytes using Epstein Barr virus (EBV) in the presence of a polyclonal B cell activator. The method is particularly useful in a method for producing a clone of an immortalised human B memory lymphocyte capable of producing a human monoclonal antibody with a desired antigen specificity, comprising the steps of: (i) selecting and isolating a human memory B lymphocyte subpopulation; (ii) transforming the subpopulation with Epstein Ban virus (EBV) in the presence of a polyclonal B cell activator; (iii) screening the culture supernatant for antigen specificity; and (iv) isolating an immortalised human B memory lymphocyte clone capable of producing a human monoclonal antibody having the desired antigen specificity.</p></abstract></us-patent-application>